Mayo Clinic and CurifyLabs study in Pharmaceutics shows 3D-printed low-dose metoprolol tablets met USP limits where manual tablet splitting failed.
Mayo Clinic and CurifyLabs study in Pharmaceutics shows 3D-printed low-dose metoprolol tablets met USP limits where manual tablet splitting failed.
CurifyLabs Position Paper
CurifyLabs reviews the EMA's Q&A on 3D printing in pharmaceuticals, emphasizing quality standards and the need for robust systems in pharmacy compounding.